HomeRNAZ • NASDAQ
Transcode Therapeutics Inc
add
$6.97
8.53%
After Hours:(4.45%)+0.31
$7.28
Closed: May 23, 6:32:36 PM UTC-4 · USD · NASDAQ · Disclaimer
In the news
Financials
Income Statement
Revenue
Net Income
Revenue
Net income
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 3.17M | -3.58% |
Net income | -12.09M | -263.27% |
Net profit margin | — | — |
Earnings per share | — | — |
EBITDA | -3.16M | 3.04% |
Effective tax rate | — | — |
Balance Sheet
Total Assets
Total Liabilities
Total assets
Total liabilities
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 11.57M | 135.45% |
Total assets | 13.19M | 80.98% |
Total liabilities | 2.90M | 7.22% |
Total equity | 10.29M | — |
Shares outstanding | 36.75K | — |
Price to book | 0.03 | — |
Return on assets | -77.39% | — |
Return on capital | -190.75% | — |
Cash Flow
Net Change in Cash
Net change in cash
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Net income | -12.09M | -263.27% |
Cash from operations | -3.10M | 21.35% |
Cash from investing | — | — |
Cash from financing | 8.85M | 45.47% |
Net change in cash | 5.76M | 168.31% |
Free cash flow | -2.35M | 8.46% |
Previous close
$7.62
Day range
$6.87 - $7.62
Year range
$6.15 - $1,838.76
Market cap
5.81M USD
Avg Volume
285.13K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
About
Founded
2016
Headquarters
Website
Employees
7
